DSM and Phynova reach global distribution agreement for blood glucose-support ingredient
Phynova has signed a global distribution and collaboration agreement for its Reducose ingredient with DSM.
Photo © stock.adobe,com/6okean
Phynova (Oxfordshire, UK) has signed a global distribution and collaboration agreement for its Reducose ingredient with DSM (Kaiseraugst, Switzerland). Reducose is a patented water extract of white mulberry leaves (Morus alba) that supports healthy blood glucose levels by reducing the absorption of sugars and other carbohydrate by up to 40%, says the company.
“We are delighted to work with DSM, the leading global health and nutrition ingredient specialist,” said Robert Miller, CEO of Phynova, in a press release. “Along with the distribution and sales of Reducose, we will collaborate closely with them on product development, clinical research, regulatory approvals, and marketing.”
“Phynova is a strategic partner for DSM to provide the right nutritional solutions to address the ever-growing health concerns linked to maintaining healthy blood glucose,” explained Ivo Lansbergen, VP global strategic marketing, DSM Human Nutrition and Health, in a press release. “The combined strengths of DSM and Phynova provide an excellent platform for addressing this major societal challenge.”
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
